These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16132582)
1. Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin. Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Gao X; Guan HW; Li H Clin Exp Metastasis; 2005; 22(1):85-93. PubMed ID: 16132582 [TBL] [Abstract][Full Text] [Related]
2. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Li H Cancer Lett; 2005 Jun; 223(2):339-47. PubMed ID: 15896469 [TBL] [Abstract][Full Text] [Related]
3. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Ramesh S; Nash J; McCulloch PG Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738 [TBL] [Abstract][Full Text] [Related]
4. Expression of e-cadherin and catenins in early gastric cancer. Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224 [TBL] [Abstract][Full Text] [Related]
5. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ Digestion; 2001; 64(2):111-9. PubMed ID: 11684825 [TBL] [Abstract][Full Text] [Related]
6. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Kim HS; Hong EK; Park SY; Kim WH; Lee HS Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124 [TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911 [TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
9. Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression. Cheng XX; Sun Y; Chen XY; Zhang KL; Kong QY; Liu J; Li H Oncol Rep; 2004 Jun; 11(6):1201-7. PubMed ID: 15138556 [TBL] [Abstract][Full Text] [Related]
10. Multinuclear giant cell formation is enhanced by down-regulation of Wnt signaling in gastric cancer cell line, AGS. Kim SM; Kim R; Ryu JH; Jho EH; Song KJ; Jang SI; Kee SH Exp Cell Res; 2005 Aug; 308(1):18-28. PubMed ID: 15878526 [TBL] [Abstract][Full Text] [Related]
11. [Expression of beta-catenin and E-cadherin in early gastric cancer: correlation with clinicopathologic parameters]. Song BJ; Park YJ; Kim HS; Kim CN; Chang SH Korean J Gastroenterol; 2004 Feb; 43(2):82-9. PubMed ID: 14978364 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
13. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342 [TBL] [Abstract][Full Text] [Related]
14. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859 [TBL] [Abstract][Full Text] [Related]
15. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842 [TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Ougolkov A; Yamashita K; Bilim V; Takahashi Y; Mai M; Minamoto T Int J Colorectal Dis; 2003 Mar; 18(2):160-6. PubMed ID: 12548420 [TBL] [Abstract][Full Text] [Related]
19. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
20. Localization of IQGAP1 is inversely correlated with intercellular adhesion mediated by e-cadherin in gastric cancers. Takemoto H; Doki Y; Shiozaki H; Imamura H; Utsunomiya T; Miyata H; Yano M; Inoue M; Fujiwara Y; Monden M Int J Cancer; 2001 Mar; 91(6):783-8. PubMed ID: 11275980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]